Navigation Links
WIRB-Copernicus Group Leaders Speak at Global Clinical Research Summit in South Korea
Date:10/1/2013

thical review services for human research. With eight individual AAHRPP-accredited panels, over 100 experienced board members, and over 60 years of combined experience in protocol and study-related review, the WIRB-Copernicus Group brings more expertise to the industry than any other ethical solutions provider.

Members of the WIRB-Copernicus Group family of companies include Western Institutional Review Board (WIRB) and Copernicus Group IRB (CGIRB), the nation's leading independent institutional review boards, and IRBNet, the top research compliance software supporting institutions. It is the mission of the WIRB-Copernicus Group to meet the highest standards of ethics and science, and to ensure the safety and welfare of research subjects worldwide. For more information, please visit www.wcgirb.com.

 


'/>"/>
SOURCE WIRB-Copernicus Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. AtheroNova and Maxwell Biotech Group Ratify Agreement to Develop New Atherosclerosis Drug
2. MiMedx Group, Inc. to Present at the 6th Annual Canaccord Genuity Cardiovascular, Aesthetics and Metabolic Disorders Conference
3. BioNeutral Group Receives $400,000 in Equity Financing
4. MiMedx Group Completes $5,000,000 Private Placement
5. Use Biomarkers in Alzheimers Disease Clinical Trials, Says Expert Group
6. MiMedx Group, Inc. Receives CE Certification for Its CollaFix™ Surgical Mesh CD
7. Lend Lease Announces the Appointment of Tom Chapman as Director Operations for the Life Sciences Group in the Atlantic Region
8. Statewide Network of Angel Investor Groups Announced in Alabama
9. Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2011 Financial Results on Wednesday, March 7, 2012
10. Weikang Bio-Technology Group Co., Inc. Is Expected to Achieve the Net Profit of at Least $26 Million
11. MiMedx Group Announces 2011 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... (PRWEB) January 15, 2014 Cynvenio, a ... management through the genomic analysis of tumor cells in ... Finder™, a web-based cancer decision support application powered by ... with Cynvenio’s ClearID™ genomic test, Therapy Finder will provide ...
(Date:1/15/2014)... 2014 A study has been launched to ... 1 track could help to tackle the problem of obesity. ... (a GP surgery based in Stowmarket) and academics at University ... Telemetry technology, which is inspired by equipment used to ...
(Date:1/15/2014)... 15, 2014 DTS Language Services, Inc ... Web Portal for Life Science organizations who need document translations. ... subject matter of their documents in advance with a selection ... time-to-delivery of translations, often a critical factor in clinical and ...
(Date:1/15/2014)... TAIPEI , Jan. 15, 2014 TaiGen Biotechnology ... an exclusive agreement with R-Pharm, a leading Russian pharmaceutical ... in the Russian Federation , ... Commonwealth Independent States (CIS). Nemonoxacin is a novel antibiotic for ...
Breaking Biology Technology:Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4DTS Improves Efficiency for Life Science Document Translations 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4
... ... Terrosa Technologies, a provider of Cloud and SaaS migration ... wide sales, marketing and distribution responsibilities with Integrated Clinical Solutions ... Clinical Trial Management System (CTMS) tool for the pharmaceutical clinical ...
... , , , ... (OTC Bulletin Board: ADLS) announced that it received a complete ... (FDA) regarding its New Drug Application (NDA) for Restanza(TM) (cethromycin) ... pneumonia (CAP). In its letter, the FDA indicated that ...
... Novavax, Inc. (Nasdaq: NVAX ) today announced that it ... release to be issued after 8:00 a.m. Eastern Time on Friday, ... to discuss its financial results at 10:00 a.m. Eastern Time on ... President and Chief Executive Officer Dr. Rahul Singhvi and other members ...
Cached Biology Technology:Terrosa Technologies Assigned as Exclusive Reseller for Inclinicalperform CTMS/SaaS Clinical Trials Collaboration Software 2Terrosa Technologies Assigned as Exclusive Reseller for Inclinicalperform CTMS/SaaS Clinical Trials Collaboration Software 3Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia 2Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia 3Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia 4Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia 5
(Date:7/9/2014)... studies suggest that children delivered by Caesarean section have a ... it is still unknown why this is the case and ... Faculty of Health and Medical Sciences therefore decided to scrutinise ... system in a study of newborn mouse pups. ... section had developed a lower number of cells that strengthen ...
(Date:7/9/2014)... switch out one gene for another in a line ... fiction to reality within this decade. As with any ... of fixing disease-causing genes in humans, for example--as well ... put one of those concerns to rest: using gene-editing ... of mutations in the cells. The new results were ...
(Date:7/9/2014)... in Indiana state parks have helped restore the health ... overabundant populations of white-tailed deer, a Purdue study shows. ... professor of forest ecology, found that a 17-year-long Indiana ... state parks has successfully spurred the regrowth of native ... deer. , Jenkins said that while hunting may ...
Breaking Biology News(10 mins):Mouse study: Natural birth may strengthen the immune system 2No extra mutations in modified stem cells, study finds 2No extra mutations in modified stem cells, study finds 3Hunting gives deer-damaged forests in state parks a shot at recovery 2
... color, their knobby knees or their big feet to their children ... through those same genes. New research from the University of ... herpes virus 6 (HHV-6) to their children because it is integrated ... been shown to become part of the human DNA and then ...
... wolves chasing deer and other hoofed animals, new research ... to hunting. The study, published today in the open ... salmon is available, wolves will reduce deer hunting activity ... the University of Victoria and the Raincoast Conservation Foundation, ...
... permafrost in northern latitudes, which greatly increases microbial decomposition ... of warming in the region and could become a ... thus further warming, according to a new assessment in ... study, by Edward A. G. Schuur of the University ...
Cached Biology News:Virus weaves itself into the DNA transferred from parents to babies 2Wolves would rather eat salmon 2Thawing permafrost likely to boost global warming 2
Rabbit polyclonal to IL23 P19 ( Abpromise for all tested applications). Antigen: Synthetic 16 amino acid peptide from near the amino terminus of human IL23 P19 Entrez Gene ID: 51561 Swiss...
Monoclonal Mouse Anti-Human Cytokeratin 16 (48 kD)...
PFM8 Antibody...
Goat anti-PITPN Class: Antibody Product Group: Miscellaneous Antibody...
Biology Products: